Skip to main content
. 2021 Jan 14;21:68. doi: 10.1186/s12885-021-07789-6

Fig. 1.

Fig. 1

Receiver operating characteristic (ROC) curves of TIN before NACT for chemotherapy efficiency (a), TIN after NACT for ineffectiveness of chemotherapy efficiency (b) and the difference of TIN before and after NACT for chemotherapy efficiency (c). The area under the ROC curve was 0.449 (95% confidence interval [CI], 0.275–0.622, P = 0.473), 0.643 (95% confidence interval [CI], 0.509–0.776, P = 0.019), 0.770 (95% confidence interval [CI], 0.657–0.883, P < 0.001), respectively